Mature B-cell non-Hodgkin lymphoma
Clinical trials for Mature B-cell non-Hodgkin lymphoma explained in plain language.
Never miss a new study
Get alerted when new Mature B-cell non-Hodgkin lymphoma trials appear
Sign up with your email to follow new studies for Mature B-cell non-Hodgkin lymphoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for young cancer patients: glofitamab trial targets tough lymphoma
Disease control Recruiting nowThis study tests a drug called glofitamab, which helps the immune system find and kill cancer cells, in children and young adults (ages 6 months to under 30) whose B-cell lymphoma has come back or not responded to treatment. Some participants receive glofitamab alone, while other…
Matched conditions: MATURE B-CELL NON-HODGKIN LYMPHOMA
Phase 1/2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New combo therapy aims to beat childhood lymphoma
Disease control Recruiting nowThis study is testing whether adding the drug rituximab early and intensively to a strong chemotherapy regimen can improve outcomes for children and teens with aggressive B-cell non-Hodgkin lymphoma. About 87 participants will receive the combination therapy. The goal is to see i…
Matched conditions: MATURE B-CELL NON-HODGKIN LYMPHOMA
Phase 2/3 • Sponsor: Children's Cancer Group, China • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC